| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | WO2003050253A3 Proteins associated with cell growth, differentiation, and death |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2002101072A3 Letm1: modulators of cellular proliferation |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034195 Expression vector comprising nucleotide sequences associated with coat specific expression of heterologous gene sequences; modifying seed caot luster |
| 02/10/2005 | US20050034194 Gene controlling flowering time of plants and method for manipulating flowering time of plant using the same |
| 02/10/2005 | US20050034193 Transcriptional activator nucleic acids, polypeptides and methods of use thereof |
| 02/10/2005 | US20050034192 Expression vector comprising tissue specific regulatory sequences for use tool in controlling heterologous gene expression in plants; generating insect resistant plants |
| 02/10/2005 | US20050034191 Transgenic canola seeds comprising sodium/proton exchange protein nucleotide sequences for use in generating/propagating plants with enhanced salt resistance |
| 02/10/2005 | US20050034189 Expression vector comprising nucleotide sequences coding scarecrow like gene for use in transformation and generation of disease-resistant recombinant crops |
| 02/10/2005 | US20050034185 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 02/10/2005 | US20050034184 Transgenic papp-a non-human mammals |
| 02/10/2005 | US20050034183 Non-human animal model for analysis of the original and therapy of organ fibrosis |
| 02/10/2005 | US20050034182 Transgenic mouse with genome DNA sequence encoding a mutated human tau protein linked to promoter; mouse brain exhibits neurofibrillary tangles; Alzheimer*s and neurodegenerative disease |
| 02/10/2005 | US20050034179 Transgenic animal cell which express tumor necrosis factor receptor for use in identifying agents for treatment of diabetes and inflammatory bowel disease |
| 02/10/2005 | US20050034178 Expression vector comprising glucose regulated protein 78 (grp78) stress-responsive promoter and endoplasmic reticulum stress elements for use in tissue specific heterologous gene expression for treatment and prevention of cell proliferative and inflammatory disorders |
| 02/10/2005 | US20050033522 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050033037 producing chelated metals that are more stable in higher alkaline environments than those chelates formed by the direct reaction of amino acids and metal compounds; formed by using oxidized or non-oxidized sugars |
| 02/10/2005 | US20050033036 An isolated DNA encoding a protein, has testicular differentiation activity |
| 02/10/2005 | US20050033035 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 02/10/2005 | US20050033034 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 02/10/2005 | US20050033025 Human papilloma viral proteins fragments for use in generating immunoglobullins for treatment and prevention infection; immunotherapeutics and diagnostice; viricides |
| 02/10/2005 | US20050033024 Expression vector comprising nucleotide sequences coding cytokine receptor for use as tool in identifying modulators for prevention and treatment allergic, skin and respiratory disorders |
| 02/10/2005 | US20050033023 Immunostimulatory parathyroid hormone-related peptide (PTH-rP) for use in diagnosis, prevention and treatment of cell proliferative disorders; tissue targeted therapy |
| 02/10/2005 | US20050033022 Fusion proteins comprising HIV-1 Tat and/or Nef proteins |
| 02/10/2005 | US20050033021 Chimeric Gatiphal 15 variants and their use in the analysis and discovery of modulators of G-protein coupled receptors |
| 02/10/2005 | US20050033020 contacting cells, which contains binding proteins and cis-acting element of CD40 3'-untranslated region linked to nucleotide sequences that code for reporter molecules, with drugs or biological targets, then detecting gene expression of the coded reporter molecule in the cell; drug screening; analyzing |
| 02/10/2005 | US20050033019 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032737 Development of hematological changes can be offset by recombinant growth hormone therapy; increases red blood cell and hemoglobin values |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032735 By preparing a recombinant vector containing an agouti-encoding DNA segment controlled by a promoter and introducing it to the skin cells |
| 02/10/2005 | US20050032732 DNA vaccine expressing HA1 of equine-2 influenza virus |
| 02/10/2005 | US20050032730 Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions |
| 02/10/2005 | US20050032729 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
| 02/10/2005 | US20050032728 Tumor suppression through bicistronic co-expression of p53 and p14ARF |
| 02/10/2005 | US20050032722 Soluble steroidal peptides for nucleic acid delivery |
| 02/10/2005 | US20050032707 Novel peptides comprising furanoid sugar amino acids for the treatment of cancer |
| 02/10/2005 | US20050032705 Alpha-conotoxin peptides |
| 02/10/2005 | US20050032704 Neural thread proteins (NTP); antiproliferative agents |
| 02/10/2005 | US20050032700 Polypeptide for use in the treatment of tumors, diabetes and arteriolosclerosis |
| 02/10/2005 | US20050032697 Heparin binding VEGFR-3 ligands |
| 02/10/2005 | US20050032696 Muscle transcription factors |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032689 Methods for treatment or diagnosis of disease or disorders associated with an APB domain |
| 02/10/2005 | US20050032686 administering to a manimal a therapeutically effective amount of ES-62 ( a glycoprotein) to treat an inflammatory disease: arthritis and chronic obstructive pulmonary disease |
| 02/10/2005 | US20050032684 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhaltion devices and method of diagnosis |
| 02/10/2005 | US20050032681 Human antithrombin iiis and methods related thereto |
| 02/10/2005 | US20050032678 Composition and method for regulation of body weight and associated conditions |
| 02/10/2005 | US20050032674 SAIF, an anti-inflammatory factor, and methods of use thereof |
| 02/10/2005 | US20050032673 Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease |
| 02/10/2005 | US20050032216 Plasmid comprising antibody specific for cell surface membrane protein receptor (5T4) for use in tissue directed treatment of tumors; tissue targeted therapy |
| 02/10/2005 | US20050032213 Expression vector comprising polynucleotide which codes conditionally-inducible oncogene operably linked to enhancer of a nestin intron for use in prevention and treatment of disease associated with cell loss and/or damage |
| 02/10/2005 | US20050032190 Beta-secretase substrates and uses thereof |
| 02/10/2005 | US20050032189 Novel protein derived from agkistrodon saxatilis emelianov and process preparing the same |
| 02/10/2005 | US20050032186 Regulatory zinc finger proteins |
| 02/10/2005 | US20050032183 Tumor necrosis factor receptor crystal protein for us in treatment and prevention of rheumatic, arthritic, psoriatic, and/or ankylosing spondylitis |
| 02/10/2005 | US20050032179 Nucleotide sequences coding for the ccpA1 gene |
| 02/10/2005 | US20050032178 Process for the fermentative preparation of L-amino acids using strains of the enterobacteriaceae family |
| 02/10/2005 | US20050032175 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 02/10/2005 | US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders |
| 02/10/2005 | US20050032173 Chimeric protein comprising I kappa B protein domains for use in prevention and treatment of skin, inflammatory, autoimmune, respiratory, cell proliferative and allergic disorders; immunosuppressant |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032171 hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032167 Expression vector comprising nucleotide sequences coding cytokine binding protein for use as tools in tissue targeted therapies; cytotoxic cell therapies |
| 02/10/2005 | US20050032166 Expression vector comprising nucleotide sequences coding adipokine binding protein for use in treatment and prevention of diabetes, obesity, inflammation, cardiovascular and metabolic disorders |
| 02/10/2005 | US20050032165 Potassium channels, nucleotide sequences encoding them, and methods of using same |
| 02/10/2005 | US20050032164 IL4 receptor antagonists for horse, dog and cat |
| 02/10/2005 | US20050032162 Epidermal growth factor agonists and methods of use |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032156 Identification and characterization of phosphate transporter genes |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032135 Screening for conjugates or agents that are actively transported by MCT1 and MCT4, which are expressed at higher levels in cancer cells; 3-bis(2-chloroethyl)amino-4-methoxybenzoic acid or bis(2-chloroethyl)aminoxyacetic acid for example; use in treatment or diagnosis of cancer |
| 02/10/2005 | US20050032134 Neoplasm-specific polypeptides and their uses |
| 02/10/2005 | US20050032131 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 02/10/2005 | US20050032125 Constitutively translocating cell line |
| 02/10/2005 | US20050032119 drug design; models; computer analysis |
| 02/10/2005 | US20050032112 Preparing transgenic, salt tolerant rice which express sodium transport protein |
| 02/10/2005 | US20050032111 Using intregral membrane protein concentration as diagnostic and/or prognostic indicator of successful pregnancy; in vitro fertilization and reproductive disorders |
| 02/10/2005 | US20050032103 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 02/10/2005 | US20050032101 Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/10/2005 | US20050032088 Nucleotide sequences coding 2,5-diketo-D-gluconic acid permease for use in enhancing ascorbic acid transport across membrane; food processing and preparation; nutraceuticals |
| 02/10/2005 | US20050032087 Using receptor-type protein tyrosine phosphatase (RPTP) as diagnostic tools in identifying modulators for treatment and prevention of cell proliferative disorders |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032083 Nucleotide sequences coding spinocerebellar ataxia-2 (SCA-2) protein for use as tools in teatment, diagnosis and prevention of nervous system disorders; immunodiagnostics |
| 02/10/2005 | US20050032079 Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer |
| 02/10/2005 | US20050032062 Methods for the assessment and prognosis of sarcoidosis |
| 02/10/2005 | US20050032050 Using sequence data to generate oligonucleotides sharing sequence homology to stress resistance genes and which can be used to screen and isolate clones comprising complimentary sequences in plant genomic libraries |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | US20050032045 Viral fusion protein comprising a portion of gut associated lymphoid tissue (GALT) cell surface binding protein for use in targeted protein delivery and immunotherapeutics; vaccines |
| 02/10/2005 | US20050032043 Recombinant negative strand RNA virus expression systems and vaccines |
| 02/10/2005 | US20050032041 Using viral protein as diagnostic indicator of infection in grapes; immunodiagnostics |
| 02/10/2005 | US20050032039 HIV-specific T-cell induction |